Delving into the Latest Updates on FJZHT03 with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Nervous System DiseasesCardiovascular Diseases

Active Indication

Angina, StableCoronary Artery Disease

Inactive Indication-

Originator Organization-

Active Organization

Jilin Institute of Traditional Chinese MedicineChangchun College of Traditional Chinese Medicine

Inactive Organization-

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

Using placebo as the control and the change in total exercise time of the exercise test as the main efficacy indicator, the clinical efficacy and safety of FJZHT03 in the treatment of angina pectoris (chest pain, qi deficiency and blood stasis syndrome) of coronary heart disease were evaluated to confirm its market value.

Start Date13 Mar 2012

Sponsor / Collaborator

Jilin Institute of Traditional Chinese Medicine

[+1]

100 Clinical Results associated with FJZHT03

Login to view more data

100 Translational Medicine associated with FJZHT03

Login to view more data

100 Patents (Medical) associated with FJZHT03

Login to view more data

100 Deals associated with FJZHT03

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Angina, Stable	Phase 3	CN	Jilin Institute of Traditional Chinese Medicine	13 Mar 2012
Angina, Stable	Phase 3	CN	Changchun College of Traditional Chinese Medicine	13 Mar 2012
Coronary Artery Disease	Phase 3	CN	Changchun College of Traditional Chinese Medicine	13 Mar 2012
Coronary Artery Disease	Phase 3	CN	Jilin Institute of Traditional Chinese Medicine	13 Mar 2012